Cart
sales@molnova.com
Insecticidal agent 364
CAS No. 556055-08-4
Insecticidal agent 364( —— )
Catalog No. M36074 CAS No. 556055-08-4
Insecticidal agent 364 is a selective small molecule inhibitor of rapamycin kinase target protein.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 28 | In Stock |
|
| 25MG | 51 | In Stock |
|
| 50MG | 75 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameInsecticidal agent 364
-
NoteResearch use only, not for human use.
-
Brief DescriptionInsecticidal agent 364 is a selective small molecule inhibitor of rapamycin kinase target protein.
-
DescriptionInsecticidal agent 364 is a selective small molecule inhibitor of rapamycin kinase target protein. Insecticidal agent 364 has antitumor activity, and by inhibiting mTOR, Insecticidal agent 364 aims to disrupt signaling pathways involved in cancer cell growth and survival, thereby potentially inhibiting tumor growth.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAutophagy
-
TargetAutophagy
-
RecptorAutophagy | mTOR
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number556055-08-4
-
Formula Weight430.48
-
Molecular FormulaC23H18N4O3S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESS(CC(=O)C=1C=C2C(=CC1)OCCO2)C=3N(C(=NN3)C=4C=CN=CC4)C5=CC=CC=C5
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Sulfathiazole
Sulfathiazole is an organosulfur compound that has been used as a short-acting sulfa drug.
-
XRK3F2
XRK3F2 is a specific ZZ-domain of ubiquitin-binding protein p62 (Sequestosome 1) inhibitor that inhibits MM cell growth and BMSC growth enhancement of human MM cells.
-
Vacuolin-1
A potent PIKfyve inhibitor that inhibits autophagy by impairing lysosomal maturation, potently and reversibly inhibits autophagosome-lysosome fusion by activating RAB5A.
